| (Values in U.S. Thousands) | Dec, 2021 | Sep, 2021 | Jun, 2021 | Mar, 2021 | Dec, 2020 |
| Sales | 40 | 270 | 610 | 640 | 720 |
| Sales Growth | -85.19% | -55.74% | -4.69% | -11.11% | +75.61% |
| Net Income | 30 | -260 | -390 | -260 | -240 |
| Net Income Growth | +111.54% | +33.33% | -50.00% | -8.33% | +64.71% |
Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Fiscal Year End Date: 12/31